Robledo, Jorge Alberto Ceballos 
; Jaramillo-Isaza, Jonnier Sebastián; Vélez, Juan Camilo Calderón; Miranda, Paulo Barbeitas ; Cadavid, Marco Antonio Giraldo
Source: Langmuir. Unidade: IFSC
Subjects: LIPÍDEOS, MOLÉCULA, MEMBRANAS CELULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROBLEDO, Jorge Alberto Ceballos et al. Doxorubicin interaction with lipid monolayers leads to decreased membrane stiffness when experiencing compression-expansion dynamics. Langmuir, v. 39, n. 25, p. 8603-8611, 2023Tradução . . Disponível em: https://doi.org/10.1021/acs.langmuir.3c00250. Acesso em: 07 nov. 2024.APA
Robledo, J. A. C., Jaramillo-Isaza, J. S., Vélez, J. C. C., Miranda, P. B., & Cadavid, M. A. G. (2023). Doxorubicin interaction with lipid monolayers leads to decreased membrane stiffness when experiencing compression-expansion dynamics. Langmuir, 39( 25), 8603-8611. doi:10.1021/acs.langmuir.3c00250NLM
Robledo JAC, Jaramillo-Isaza JS, Vélez JCC, Miranda PB, Cadavid MAG. Doxorubicin interaction with lipid monolayers leads to decreased membrane stiffness when experiencing compression-expansion dynamics [Internet]. Langmuir. 2023 ; 39( 25): 8603-8611.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1021/acs.langmuir.3c00250Vancouver
Robledo JAC, Jaramillo-Isaza JS, Vélez JCC, Miranda PB, Cadavid MAG. Doxorubicin interaction with lipid monolayers leads to decreased membrane stiffness when experiencing compression-expansion dynamics [Internet]. Langmuir. 2023 ; 39( 25): 8603-8611.[citado 2024 nov. 07 ] Available from: https://doi.org/10.1021/acs.langmuir.3c00250
